Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation
Atrial fibrillation is associated with increased morbidity and mortality 1 – 5 and is an independent risk factor for stroke. 6 , 7 Although the association between atrial fibrillation and mortality has been debated, a recent report showed that atrial fibrillation was associated with a mortality rate...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2001-04, Vol.344 (14), p.1043-1051 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1051 |
|---|---|
| container_issue | 14 |
| container_start_page | 1043 |
| container_title | The New England journal of medicine |
| container_volume | 344 |
| creator | Ozcan, Cevher Jahangir, Arshad Friedman, Paul A Patel, Philip J Munger, Thomas M Rea, Robert F Lloyd, Margaret A Packer, Douglas L Hodge, David O Hayes, David L Gersh, Bernard J Hammill, Stephen C Shen, Win-Kuang |
| description | Atrial fibrillation is associated with increased morbidity and mortality
1
–
5
and is an independent risk factor for stroke.
6
,
7
Although the association between atrial fibrillation and mortality has been debated, a recent report showed that atrial fibrillation was associated with a mortality rate that was higher by a factor of 1.5 to 1.9 than the rate expected in the general population, after adjustment for other cardiovascular conditions.
1
The optimal goal in treating atrial fibrillation is to restore and maintain sinus rhythm — often a formidable task. Despite therapy with antiarrhythmic drugs, studies have reported recurrence rates of 50 to 60 . . . |
| doi_str_mv | 10.1056/NEJM200104053441403 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77000411</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77000411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-6a9753f60c9551f47ed8b57d20bfb2dee480947459a0a077c49b1f4e0d36e23c3</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYNY7Lb6CQQJCr7I6M2_yeRxKa22bGvB-jxkMhmbdZJZk8xKP4Tf2dRdWhAxL5eE3z3nkIPQSwLvCYj6w9XpxSUFIMBBMM4JB_YELYhgrOIc6qdoAUCbikvFDtFRSmsoh3D1DB0SQhupJF-gX6spfKtubPT4yxy3bqtHrIdsI152o85uCngacL61eJmjm7Y2lGHmUUd8NfUW69Djc78ZdcgPtMbXRU-HwuJrbazX34ueC-WSXXlM-KfLt38Ei9uZ66Ibd17P0cGgx2Rf7Ocx-np2enPyqVp9_nh-slxVRtAmV7VWUrChBqOEIAOXtm86IXsK3dDR3lregOKSC6VBg5SGq65gFnpWW8oMO0Zvd7qbOP2Ybcqtd8nYkiLYaU6tlOWrOCEFfP0XuJ7mGEq2llKmOKeKF4jtIBOnlKId2k10Xse7lkB7X1X7j6rK1qu99Nx52z_u7LspwJs9oJPR4xB1MC49cMUY6vuE73aU96kNdu3_a_obC0Kn8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223944294</pqid></control><display><type>article</type><title>Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Ozcan, Cevher ; Jahangir, Arshad ; Friedman, Paul A ; Patel, Philip J ; Munger, Thomas M ; Rea, Robert F ; Lloyd, Margaret A ; Packer, Douglas L ; Hodge, David O ; Hayes, David L ; Gersh, Bernard J ; Hammill, Stephen C ; Shen, Win-Kuang</creator><creatorcontrib>Ozcan, Cevher ; Jahangir, Arshad ; Friedman, Paul A ; Patel, Philip J ; Munger, Thomas M ; Rea, Robert F ; Lloyd, Margaret A ; Packer, Douglas L ; Hodge, David O ; Hayes, David L ; Gersh, Bernard J ; Hammill, Stephen C ; Shen, Win-Kuang</creatorcontrib><description>Atrial fibrillation is associated with increased morbidity and mortality
1
–
5
and is an independent risk factor for stroke.
6
,
7
Although the association between atrial fibrillation and mortality has been debated, a recent report showed that atrial fibrillation was associated with a mortality rate that was higher by a factor of 1.5 to 1.9 than the rate expected in the general population, after adjustment for other cardiovascular conditions.
1
The optimal goal in treating atrial fibrillation is to restore and maintain sinus rhythm — often a formidable task. Despite therapy with antiarrhythmic drugs, studies have reported recurrence rates of 50 to 60 . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM200104053441403</identifier><identifier>PMID: 11287974</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - complications ; Atrial Fibrillation - mortality ; Atrial Fibrillation - therapy ; Atrioventricular Node - surgery ; Biological and medical sciences ; Cardiac arrhythmia ; Cardiac dysrhythmias ; Cardiology ; Cardiology. Vascular system ; Case-Control Studies ; Catheter Ablation ; Cause of Death ; Combined Modality Therapy ; Diseases of the cardiovascular system ; Female ; Follow-Up Studies ; Heart ; Heart Failure - complications ; Humans ; Male ; Medical sciences ; Middle Aged ; Mortality ; Myocardial Infarction - complications ; Pacemaker, Artificial ; Proportional Hazards Models ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Survival Analysis ; Survival Rate ; Transplants & implants</subject><ispartof>The New England journal of medicine, 2001-04, Vol.344 (14), p.1043-1051</ispartof><rights>Copyright © 2001 Massachusetts Medical Society. All rights reserved.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-6a9753f60c9551f47ed8b57d20bfb2dee480947459a0a077c49b1f4e0d36e23c3</citedby><cites>FETCH-LOGICAL-c528t-6a9753f60c9551f47ed8b57d20bfb2dee480947459a0a077c49b1f4e0d36e23c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM200104053441403$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM200104053441403$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=943061$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11287974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozcan, Cevher</creatorcontrib><creatorcontrib>Jahangir, Arshad</creatorcontrib><creatorcontrib>Friedman, Paul A</creatorcontrib><creatorcontrib>Patel, Philip J</creatorcontrib><creatorcontrib>Munger, Thomas M</creatorcontrib><creatorcontrib>Rea, Robert F</creatorcontrib><creatorcontrib>Lloyd, Margaret A</creatorcontrib><creatorcontrib>Packer, Douglas L</creatorcontrib><creatorcontrib>Hodge, David O</creatorcontrib><creatorcontrib>Hayes, David L</creatorcontrib><creatorcontrib>Gersh, Bernard J</creatorcontrib><creatorcontrib>Hammill, Stephen C</creatorcontrib><creatorcontrib>Shen, Win-Kuang</creatorcontrib><title>Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Atrial fibrillation is associated with increased morbidity and mortality
1
–
5
and is an independent risk factor for stroke.
6
,
7
Although the association between atrial fibrillation and mortality has been debated, a recent report showed that atrial fibrillation was associated with a mortality rate that was higher by a factor of 1.5 to 1.9 than the rate expected in the general population, after adjustment for other cardiovascular conditions.
1
The optimal goal in treating atrial fibrillation is to restore and maintain sinus rhythm — often a formidable task. Despite therapy with antiarrhythmic drugs, studies have reported recurrence rates of 50 to 60 . . .</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - mortality</subject><subject>Atrial Fibrillation - therapy</subject><subject>Atrioventricular Node - surgery</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrhythmia</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Case-Control Studies</subject><subject>Catheter Ablation</subject><subject>Cause of Death</subject><subject>Combined Modality Therapy</subject><subject>Diseases of the cardiovascular system</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart Failure - complications</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Myocardial Infarction - complications</subject><subject>Pacemaker, Artificial</subject><subject>Proportional Hazards Models</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><subject>Transplants & implants</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kV9rFDEUxYNY7Lb6CQQJCr7I6M2_yeRxKa22bGvB-jxkMhmbdZJZk8xKP4Tf2dRdWhAxL5eE3z3nkIPQSwLvCYj6w9XpxSUFIMBBMM4JB_YELYhgrOIc6qdoAUCbikvFDtFRSmsoh3D1DB0SQhupJF-gX6spfKtubPT4yxy3bqtHrIdsI152o85uCngacL61eJmjm7Y2lGHmUUd8NfUW69Djc78ZdcgPtMbXRU-HwuJrbazX34ueC-WSXXlM-KfLt38Ei9uZ66Ibd17P0cGgx2Rf7Ocx-np2enPyqVp9_nh-slxVRtAmV7VWUrChBqOEIAOXtm86IXsK3dDR3lregOKSC6VBg5SGq65gFnpWW8oMO0Zvd7qbOP2Ybcqtd8nYkiLYaU6tlOWrOCEFfP0XuJ7mGEq2llKmOKeKF4jtIBOnlKId2k10Xse7lkB7X1X7j6rK1qu99Nx52z_u7LspwJs9oJPR4xB1MC49cMUY6vuE73aU96kNdu3_a_obC0Kn8w</recordid><startdate>20010405</startdate><enddate>20010405</enddate><creator>Ozcan, Cevher</creator><creator>Jahangir, Arshad</creator><creator>Friedman, Paul A</creator><creator>Patel, Philip J</creator><creator>Munger, Thomas M</creator><creator>Rea, Robert F</creator><creator>Lloyd, Margaret A</creator><creator>Packer, Douglas L</creator><creator>Hodge, David O</creator><creator>Hayes, David L</creator><creator>Gersh, Bernard J</creator><creator>Hammill, Stephen C</creator><creator>Shen, Win-Kuang</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20010405</creationdate><title>Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation</title><author>Ozcan, Cevher ; Jahangir, Arshad ; Friedman, Paul A ; Patel, Philip J ; Munger, Thomas M ; Rea, Robert F ; Lloyd, Margaret A ; Packer, Douglas L ; Hodge, David O ; Hayes, David L ; Gersh, Bernard J ; Hammill, Stephen C ; Shen, Win-Kuang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-6a9753f60c9551f47ed8b57d20bfb2dee480947459a0a077c49b1f4e0d36e23c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - mortality</topic><topic>Atrial Fibrillation - therapy</topic><topic>Atrioventricular Node - surgery</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrhythmia</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Case-Control Studies</topic><topic>Catheter Ablation</topic><topic>Cause of Death</topic><topic>Combined Modality Therapy</topic><topic>Diseases of the cardiovascular system</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart Failure - complications</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Myocardial Infarction - complications</topic><topic>Pacemaker, Artificial</topic><topic>Proportional Hazards Models</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozcan, Cevher</creatorcontrib><creatorcontrib>Jahangir, Arshad</creatorcontrib><creatorcontrib>Friedman, Paul A</creatorcontrib><creatorcontrib>Patel, Philip J</creatorcontrib><creatorcontrib>Munger, Thomas M</creatorcontrib><creatorcontrib>Rea, Robert F</creatorcontrib><creatorcontrib>Lloyd, Margaret A</creatorcontrib><creatorcontrib>Packer, Douglas L</creatorcontrib><creatorcontrib>Hodge, David O</creatorcontrib><creatorcontrib>Hayes, David L</creatorcontrib><creatorcontrib>Gersh, Bernard J</creatorcontrib><creatorcontrib>Hammill, Stephen C</creatorcontrib><creatorcontrib>Shen, Win-Kuang</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozcan, Cevher</au><au>Jahangir, Arshad</au><au>Friedman, Paul A</au><au>Patel, Philip J</au><au>Munger, Thomas M</au><au>Rea, Robert F</au><au>Lloyd, Margaret A</au><au>Packer, Douglas L</au><au>Hodge, David O</au><au>Hayes, David L</au><au>Gersh, Bernard J</au><au>Hammill, Stephen C</au><au>Shen, Win-Kuang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2001-04-05</date><risdate>2001</risdate><volume>344</volume><issue>14</issue><spage>1043</spage><epage>1051</epage><pages>1043-1051</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Atrial fibrillation is associated with increased morbidity and mortality
1
–
5
and is an independent risk factor for stroke.
6
,
7
Although the association between atrial fibrillation and mortality has been debated, a recent report showed that atrial fibrillation was associated with a mortality rate that was higher by a factor of 1.5 to 1.9 than the rate expected in the general population, after adjustment for other cardiovascular conditions.
1
The optimal goal in treating atrial fibrillation is to restore and maintain sinus rhythm — often a formidable task. Despite therapy with antiarrhythmic drugs, studies have reported recurrence rates of 50 to 60 . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>11287974</pmid><doi>10.1056/NEJM200104053441403</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2001-04, Vol.344 (14), p.1043-1051 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77000411 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine |
| subjects | Adult Aged Aged, 80 and over Analysis of Variance Anti-Arrhythmia Agents - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - mortality Atrial Fibrillation - therapy Atrioventricular Node - surgery Biological and medical sciences Cardiac arrhythmia Cardiac dysrhythmias Cardiology Cardiology. Vascular system Case-Control Studies Catheter Ablation Cause of Death Combined Modality Therapy Diseases of the cardiovascular system Female Follow-Up Studies Heart Heart Failure - complications Humans Male Medical sciences Middle Aged Mortality Myocardial Infarction - complications Pacemaker, Artificial Proportional Hazards Models Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Survival Analysis Survival Rate Transplants & implants |
| title | Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T06%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Survival%20after%20Ablation%20of%20the%20Atrioventricular%20Node%20and%20Implantation%20of%20a%20Permanent%20Pacemaker%20in%20Patients%20with%20Atrial%20Fibrillation&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Ozcan,%20Cevher&rft.date=2001-04-05&rft.volume=344&rft.issue=14&rft.spage=1043&rft.epage=1051&rft.pages=1043-1051&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM200104053441403&rft_dat=%3Cproquest_cross%3E77000411%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223944294&rft_id=info:pmid/11287974&rfr_iscdi=true |